Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 349

Similar articles for PubMed (Select 22896678)

1.

Elicitation of broadly neutralizing influenza antibodies in animals with previous influenza exposure.

Wei CJ, Yassine HM, McTamney PM, Gall JG, Whittle JR, Boyington JC, Nabel GJ.

Sci Transl Med. 2012 Aug 15;4(147):147ra114. doi: 10.1126/scitranslmed.3004273.

2.

Eliciting neutralizing antibodies against the membrane proximal external region of HIV-1 Env by chimeric live attenuated influenza A virus vaccines.

Zang Y, Du D, Li N, Su W, Liu X, Zhang Y, Nie J, Wang Y, Kong W, Jiang C.

Vaccine. 2015 Jun 27. pii: S0264-410X(15)00873-7. doi: 10.1016/j.vaccine.2015.06.072. [Epub ahead of print]

PMID:
26126669
3.

Committing the Oldest Sins in the Newest Kind of Ways-Antibodies Targeting the Influenza Virus Type A Hemagglutinin Globular Head.

Krause JC, Crowe JE Jr.

Microbiol Spectr. 2014 Oct;2(5). doi: 10.1128/microbiolspec.AID-0021-2014.

PMID:
26104373
4.

Multi-Dimensional Measurement of Antibody-Mediated Heterosubtypic Immunity to Influenza.

Wang J, Hilchey SP, Hyrien O, Huertas N, Perry S, Ramanunninair M, Bucher D, Zand MS.

PLoS One. 2015 Jun 23;10(6):e0129858. doi: 10.1371/journal.pone.0129858. eCollection 2015.

5.

Broadly Neutralizing Antibodies and the Development of Vaccines.

Haynes BF, Bradley T.

JAMA. 2015 Jun 23-30;313(24):2419-20. doi: 10.1001/jama.2015.2427. No abstract available.

PMID:
26103022
6.

Corrigendum: A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus.

Dejnirattisai W, Wongwiwat W, Supasa S, Zhang X, Dai X, Rouvinsky A, Jumnainsong A, Edwards C, Quyen NT, Duangchinda T, Grimes JM, Tsai WY, Lai CY, Wang WK, Malasit P, Farrar J, Simmons CP, Zhou ZH, Rey FA, Mongkolsapaya J, Screaton GR.

Nat Immunol. 2015 Jun 18;16(7):785. doi: 10.1038/ni0715-785a. No abstract available.

PMID:
26086146
7.

H5N1 Vaccine-Elicited Memory B Cells Are Genetically Constrained by the IGHV Locus in the Recognition of a Neutralizing Epitope in the Hemagglutinin Stem.

Wheatley AK, Whittle JR, Lingwood D, Kanekiyo M, Yassine HM, Ma SS, Narpala SR, Prabhakaran MS, Matus-Nicodemos RA, Bailer RT, Nabel GJ, Graham BS, Ledgerwood JE, Koup RA, McDermott AB.

J Immunol. 2015 Jul 15;195(2):602-10. doi: 10.4049/jimmunol.1402835. Epub 2015 Jun 15.

PMID:
26078272
8.

Construction and Immunogenicity Evaluation of Recombinant Influenza A Viruses Containing Chimeric Hemagglutinin Genes Derived from Genetically Divergent Influenza A H1N1 Subtype Viruses.

McCormick K, Jiang Z, Zhu L, Lawson SR, Langenhorst R, Ransburgh R, Brunick C, Tracy MC, Hurtig HR, Mabee LM, Mingo M, Li Y, Webby RJ, Huber VC, Fang Y.

PLoS One. 2015 Jun 10;10(6):e0127649. doi: 10.1371/journal.pone.0127649. eCollection 2015.

9.

Competitive detection of influenza neutralizing antibodies using a novel bivalent fluorescence-based microneutralization assay (BiFMA).

Baker SF, Nogales A, Santiago FW, Topham DJ, Martínez-Sobrido L.

Vaccine. 2015 Jul 9;33(30):3562-70. doi: 10.1016/j.vaccine.2015.05.049. Epub 2015 Jun 1.

PMID:
26044496
10.

Catch Me If You Can - The Race Between HIV and Neutralizing Antibodies.

Geiß Y, Dietrich U.

AIDS Rev. 2015 Apr-Jun;17(2):107-13.

PMID:
26035168
11.

Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses.

Wohlbold TJ, Nachbagauer R, Margine I, Tan GS, Hirsh A, Krammer F.

Vaccine. 2015 Jun 26;33(29):3314-21. doi: 10.1016/j.vaccine.2015.05.038. Epub 2015 May 28.

PMID:
26026378
12.

Focused antibody response to influenza linked to antigenic drift.

Huang KY, Rijal P, Schimanski L, Powell TJ, Lin TY, McCauley JW, Daniels RS, Townsend AR.

J Clin Invest. 2015 Jul 1;125(7):2631-45. doi: 10.1172/JCI81104. Epub 2015 May 26.

PMID:
26011643
13.

Pseudotype-based neutralization assays for influenza: a systematic analysis.

Carnell GW, Ferrara F, Grehan K, Thompson CP, Temperton NJ.

Front Immunol. 2015 Apr 29;6:161. doi: 10.3389/fimmu.2015.00161. eCollection 2015. Review.

14.

Measuring the neutralization potency of influenza A virus hemagglutinin stalk/stem-binding antibodies in polyclonal preparations by microneutralization assay.

He W, Mullarkey CE, Miller MS.

Methods. 2015 May 6. pii: S1046-2023(15)00191-7. doi: 10.1016/j.ymeth.2015.04.037. [Epub ahead of print]

PMID:
25957674
15.

Direct Administration in the Respiratory Tract Improves Efficacy of Broadly Neutralizing Anti-Influenza Virus Monoclonal Antibodies.

Leyva-Grado VH, Tan GS, Leon PE, Yondola M, Palese P.

Antimicrob Agents Chemother. 2015 Jul;59(7):4162-72. doi: 10.1128/AAC.00290-15. Epub 2015 May 4.

PMID:
25941218
16.

Strategies to guide the antibody affinity maturation process.

Doria-Rose NA, Joyce MG.

Curr Opin Virol. 2015 Apr;11:137-147. doi: 10.1016/j.coviro.2015.04.002. Epub 2015 Apr 24. Review.

PMID:
25913818
17.

Corrigendum: A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus.

Dejnirattisai W, Wongwiwat W, Supasa S, Zhang X, Dai X, Rouvinsky A, Jumnainsong A, Edwards C, Quyen NT, Duangchinda T, Grimes JM, Tsai WY, Lai CY, Wang WK, Malasit P, Farrar J, Simmons CP, Zhou ZH, Rey FA, Mongkolsapaya J, Screaton GR.

Nat Immunol. 2015 May;16(5):544. doi: 10.1038/ni0515-544b. No abstract available.

PMID:
25898199
18.

Progress on adenovirus-vectored universal influenza vaccines.

Xiang K, Ying G, Yan Z, Shanshan Y, Lei Z, Hongjun L, Maosheng S.

Hum Vaccin Immunother. 2015 May 4;11(5):1209-22. doi: 10.1080/21645515.2015.1016674.

PMID:
25876176
19.

Influenza virus antigenicity and broadly neutralizing epitopes.

Air GM.

Curr Opin Virol. 2015 Apr;11:113-121. doi: 10.1016/j.coviro.2015.03.006. Epub 2015 Apr 4. Review.

PMID:
25846699
20.

Prospects of HA-based universal influenza vaccine.

Hashem AM.

Biomed Res Int. 2015;2015:414637. doi: 10.1155/2015/414637. Epub 2015 Feb 15. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk